Positron emission tomography (PET) imaging with 18F-prostate-specific membrane antigen (PSMA) ligands has been recently introduced into routine imaging practice of patients with PCa, assisting both in primary diagnosis and recurrencies (1). The gene discussed is FOLH1; the disease is posterior cortical atrophy.